H M Dhingra1, W K Murphy, R J Winn, M N Raber, W K Hong. Show Affiliations » 1. Department of Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston 77030.
Abstract
Entities: Chemical Disease
Mesh: See more » AgedAged, 80 and overAntimetabolites, Antineoplastic/adverse effectsAntimetabolites, Antineoplastic/therapeutic useAzacitidine/adverse effectsAzacitidine/analogs & derivativesAzacitidine/therapeutic useDrug EvaluationFemaleHumansMaleMesothelioma/drug therapyMiddle AgedPleural Neoplasms/drug therapy
Substances: See more » Antimetabolites, Antineoplastic5,6-dihydro-5-azacytidineAzacitidine
Year: 1991 PMID: 1709153 DOI: 10.1007/bf00194548
Source DB: PubMed Journal: Invest New Drugs ISSN: 0167-6997 Impact factor: 3.850